Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥1.5 32 36 32 36 O
x 37 38 37 38 I-lower_bound
109 39 42 39 42 I-lower_bound
/ 42 43 42 43 I-lower_bound
L 43 44 43 44 I-lower_bound

Active 0 6 45 51 B-chronic_disease
, 6 7 51 52 O
uncontrolled 8 20 53 65 B-chronic_disease
bacterial 21 30 66 75 I-chronic_disease
, 30 31 75 76 O
viral 32 37 77 82 B-chronic_disease
, 37 38 82 83 O
fungal 39 45 84 90 B-chronic_disease
, 45 46 90 91 O
or 47 49 92 94 O
other 50 55 95 100 O
opportunistic 56 69 101 114 B-chronic_disease
infection 70 79 115 124 I-chronic_disease
requiring 80 89 125 134 O
systemic 90 98 135 143 B-treatment
therapy 99 106 144 151 I-treatment

Alanine 0 7 152 159 B-clinical_variable
transaminase 8 20 160 172 I-clinical_variable
( 21 22 173 174 I-clinical_variable
ALT 22 25 174 177 I-clinical_variable
) 25 26 177 178 I-clinical_variable
and 27 30 179 182 O
aspartate 31 40 183 192 B-clinical_variable
transaminase 41 53 193 205 I-clinical_variable
( 54 55 206 207 I-clinical_variable
AST 55 58 207 210 I-clinical_variable
) 58 59 210 211 I-clinical_variable
within 60 66 212 218 O
1.5x 67 71 219 223 B-upper_bound
upper 72 77 224 229 I-upper_bound
limit 78 83 230 235 I-upper_bound
of 84 86 236 238 I-upper_bound
normal 87 93 239 245 I-upper_bound

Angina 0 6 246 252 B-chronic_disease
pectoris 7 15 253 261 I-chronic_disease

Any 0 3 262 265 O
serious 4 11 266 273 O
and/or 12 18 274 280 O
unstable 19 27 281 289 O
pre 28 31 290 293 O
- 31 32 293 294 O
existing 32 40 294 302 O
medical 41 48 303 310 O
, 48 49 310 311 O
psychiatric 50 61 312 323 B-chronic_disease
, 61 62 323 324 O
or 63 65 325 327 O
other 66 71 328 333 O
condition 72 81 334 343 O
( 82 83 344 345 O
e.g. 83 87 345 349 O
, 87 88 349 350 O
severe 89 95 351 357 O
hepatic 96 103 358 365 B-chronic_disease
impairment 104 114 366 376 I-chronic_disease
) 114 115 376 377 O
or 116 118 378 380 O
current 119 126 381 388 O
unstable 127 135 389 397 O
or 136 138 398 400 O
uncompensated 139 152 401 414 O
respiratory 153 164 415 426 B-chronic_disease
or 165 167 427 429 O
cardiac 168 175 430 437 B-chronic_disease
conditions 176 186 438 448 I-chronic_disease
which 187 192 449 454 O
makes 193 198 455 460 O
it 199 201 461 463 O
undesirable 202 213 464 475 O
for 214 217 476 479 O
the 218 221 480 483 O
patient 222 229 484 491 O
to 230 232 492 494 O
participate 233 244 495 506 O
in 245 247 507 509 O
the 248 251 510 513 O
study 252 257 514 519 O
or 258 260 520 522 O
which 261 266 523 528 O
could 267 272 529 534 O
jeopardize 273 283 535 545 O
compliance 284 294 546 556 O
with 295 299 557 561 O
the 300 303 562 565 O
protocol 304 312 566 574 O

Calculated 0 10 575 585 B-clinical_variable
creatinine 11 21 586 596 I-clinical_variable
clearance 22 31 597 606 I-clinical_variable
> 32 33 607 608 O
50 33 35 608 610 B-lower_bound
mL 36 38 611 613 I-lower_bound
/ 38 39 613 614 I-lower_bound
min 39 42 614 617 I-lower_bound

Cancer 0 6 618 624 B-cancer
that 7 11 625 629 O
is 12 14 630 632 O
recurrent 15 24 633 642 O
, 24 25 642 643 O
metastatic 26 36 644 654 B-cancer
, 36 37 654 655 O
or 38 40 656 658 O
unresectable 41 53 659 671 O
and 54 57 672 675 O
for 58 61 676 679 O
which 62 67 680 685 O
no 68 70 686 688 O
effective 71 80 689 698 O
or 81 83 699 701 O
curative 84 92 702 710 O
measures 93 101 711 719 O
exist 102 107 720 725 O

Congestive 0 10 726 736 B-chronic_disease
heart 11 16 737 742 I-chronic_disease
failure 17 24 743 750 I-chronic_disease
of 25 27 751 753 O
New 28 31 754 757 B-clinical_variable
York 32 36 758 762 I-clinical_variable
Heart 37 42 763 768 I-clinical_variable
Association 43 54 769 780 I-clinical_variable
( 55 56 781 782 I-clinical_variable
NYHA 56 60 782 786 I-clinical_variable
) 60 61 786 787 I-clinical_variable
Grade 62 67 788 793 O
> 68 69 794 795 O
2 69 70 795 796 B-lower_bound

European 0 8 797 805 B-clinical_variable
Cooperative 9 20 806 817 I-clinical_variable
Oncology 21 29 818 826 I-clinical_variable
Group 30 35 827 832 I-clinical_variable
( 36 37 833 834 I-clinical_variable
ECOG 37 41 834 838 I-clinical_variable
) 41 42 838 839 I-clinical_variable
performance 43 54 840 851 I-clinical_variable
status 55 61 852 858 I-clinical_variable
0 62 63 859 860 B-lower_bound
or 64 66 861 863 O
1 67 68 864 865 B-upper_bound

HPV 0 3 866 869 B-chronic_disease
- 3 4 869 870 O
positive 4 12 870 878 O
status 13 19 879 885 O
( 20 21 886 887 O
In 22 24 888 890 O
HNSCC 25 30 891 896 B-cancer
patients 31 39 897 905 O
only 40 44 906 910 O
) 44 45 910 911 O

Hemoglobin 0 10 912 922 B-clinical_variable
≥9.0 11 15 923 927 O
g 16 17 928 929 I-lower_bound
/ 17 18 929 930 I-lower_bound
dL 18 20 930 932 I-lower_bound

History 0 7 933 940 O
of 8 10 941 943 O
clinically 11 21 944 954 O
significant 22 33 955 966 O
or 34 36 967 969 O
uncontrolled 37 49 970 982 O
cardiac 50 57 983 990 B-chronic_disease
disease 58 65 991 998 I-chronic_disease

Hormone 0 7 999 1006 B-treatment
treatments 8 18 1007 1017 I-treatment
must 19 23 1018 1022 O
be 24 26 1023 1025 O
discontinued 27 39 1026 1038 O
for 40 43 1039 1042 O
at 44 46 1043 1045 O
least 47 52 1046 1051 O
28 53 55 1052 1054 B-lower_bound
days 56 60 1055 1059 I-lower_bound
prior 61 66 1060 1065 I-lower_bound
to 67 69 1066 1068 O
the 70 73 1069 1072 O
first 74 79 1073 1078 O
administration 80 94 1079 1093 O
of 95 97 1094 1096 O
COTI-2 98 104 1097 1103 B-cancer

Inability 0 9 1104 1113 O
to 10 12 1114 1116 O
tolerate 13 21 1117 1125 O
oral 22 26 1126 1130 B-treatment
medications 27 38 1131 1142 I-treatment

Left 0 4 1143 1147 B-clinical_variable
ventricular 5 16 1148 1159 I-clinical_variable
ejection 17 25 1160 1168 I-clinical_variable
fraction 26 34 1169 1177 I-clinical_variable
( 35 36 1178 1179 I-clinical_variable
LVEF 36 40 1179 1183 I-clinical_variable
) 40 41 1183 1184 I-clinical_variable
≥55 42 45 1185 1188 O
% 45 46 1188 1189 I-lower_bound
( 47 48 1190 1191 O
or 48 50 1191 1193 O
the 51 54 1194 1197 O
institutional 55 68 1198 1211 O
lower 69 74 1212 1217 O
limit 75 80 1218 1223 O
of 81 83 1224 1226 O
normal 84 90 1227 1233 O
[ 91 92 1234 1235 O
LLN 92 95 1235 1238 O
] 95 96 1238 1239 O
) 96 97 1239 1240 O
as 98 100 1241 1243 O
evidenced 101 110 1244 1253 O
on 111 113 1254 1256 O
ECHO 114 118 1257 1261 B-treatment

Life 0 4 1262 1266 B-clinical_variable
expectancy 5 15 1267 1277 I-clinical_variable
≥3 16 18 1278 1280 O
months 19 25 1281 1287 I-lower_bound

Major 0 5 1288 1293 B-treatment
surgery 6 13 1294 1301 I-treatment
, 13 14 1301 1302 O
excluding 15 24 1303 1312 O
skin 25 29 1313 1317 B-treatment
biopsies 30 38 1318 1326 I-treatment
and 39 42 1327 1330 I-treatment
procedures 43 53 1331 1341 I-treatment
for 54 57 1342 1345 I-treatment
insertion 58 67 1346 1355 I-treatment
of 68 70 1356 1358 I-treatment
central 71 78 1359 1366 I-treatment
venous 79 85 1367 1373 I-treatment
access 86 92 1374 1380 I-treatment
devices 93 100 1381 1388 I-treatment
, 100 101 1388 1389 O
within 102 108 1390 1396 O
28 109 111 1397 1399 B-upper_bound
days 112 116 1400 1404 I-upper_bound
prior 117 122 1405 1410 I-upper_bound
to 123 125 1411 1413 O
the 126 129 1414 1417 O
start 130 135 1418 1423 O
of 136 138 1424 1426 O
COTI-2 139 145 1427 1433 B-treatment

Myocardial 0 10 1434 1444 B-chronic_disease
infarction 11 21 1445 1455 I-chronic_disease

Part 0 4 1456 1460 O
1 5 6 1461 1462 O
: 6 7 1462 1463 O
Ovarian 8 15 1464 1471 B-cancer
, 15 16 1471 1472 O
fallopian 17 26 1473 1482 B-cancer
tube 27 31 1483 1487 I-cancer
, 31 32 1487 1488 O
primary 33 40 1489 1496 B-cancer
peritoneal 41 51 1497 1507 I-cancer
, 51 52 1507 1508 O
endometrial 53 64 1509 1520 B-cancer
, 64 65 1520 1521 O
or 66 68 1522 1524 O
cervical 69 77 1525 1533 B-cancer
cancer 78 84 1534 1540 I-cancer

Part 0 4 1541 1545 O
2 5 6 1546 1547 O
: 6 7 1547 1548 O
HNSCC 8 13 1549 1554 B-cancer
, 13 14 1554 1555 O
with 15 19 1556 1560 O
confirmed 20 29 1561 1570 O
p53 30 33 1571 1574 O
mutations 34 43 1575 1584 O

Part 0 4 1585 1589 O
3 5 6 1590 1591 O
: 6 7 1591 1592 O
Gynecological 8 21 1593 1606 B-cancer
malignancies 22 34 1607 1619 I-cancer
, 34 35 1619 1620 O
HNSCC 36 41 1621 1626 B-cancer
, 41 42 1626 1627 O
colorectal 43 53 1628 1638 B-cancer
, 53 54 1638 1639 O
lung 55 59 1640 1644 B-cancer
, 59 60 1644 1645 O
pancreatic 61 71 1646 1656 B-cancer
cancer 72 78 1657 1663 I-cancer
, 78 79 1663 1664 O
or 80 82 1665 1667 O
other 83 88 1668 1673 O
tumors 89 95 1674 1680 B-cancer
with 96 100 1681 1685 O
Sponsor 101 108 1686 1693 O
approval 109 117 1694 1702 O

Partial 0 7 1703 1710 B-clinical_variable
thromboplastin 8 22 1711 1725 I-clinical_variable
time 23 27 1726 1730 I-clinical_variable
( 28 29 1731 1732 I-clinical_variable
PTT 29 32 1732 1735 I-clinical_variable
) 32 33 1735 1736 I-clinical_variable
within 34 40 1737 1743 O
1.5x 41 45 1744 1748 B-upper_bound
upper 46 51 1749 1754 I-upper_bound
limit 52 57 1755 1760 I-upper_bound
of 58 60 1761 1763 I-upper_bound
normal 61 67 1764 1770 I-upper_bound

Patients 0 8 1771 1779 O
enrolled 9 17 1780 1788 O
in 18 20 1789 1791 O
the 21 24 1792 1795 O
expansion 25 34 1796 1805 O
phase 35 40 1806 1811 O
must 41 45 1812 1816 O
be 46 48 1817 1819 O
willing 49 56 1820 1827 O
to 57 59 1828 1830 O
undergo 60 67 1831 1838 O
pre 68 71 1839 1842 O
and 72 75 1843 1846 O
post 76 80 1847 1851 O
- 80 81 1851 1852 O
Cycle 81 86 1852 1857 O
1 87 88 1858 1859 O
biopsies 89 97 1860 1868 B-treatment

Physiologically 0 15 1869 1884 O
incapable 16 25 1885 1894 O
of 26 28 1895 1897 O
becoming 29 37 1898 1906 B-pregnancy
pregnant 38 46 1907 1915 I-pregnancy
, 46 47 1915 1916 O
postmenopausal 48 62 1917 1931 O
, 62 63 1931 1932 O
or 64 66 1933 1935 O
negative 67 75 1936 1944 B-pregnancy
pregnancy 76 85 1945 1954 I-pregnancy
test 86 90 1955 1959 O
and 91 94 1960 1963 O
agree 95 100 1964 1969 B-contraception_consent
to 101 103 1970 1972 I-contraception_consent
use 104 107 1973 1976 I-contraception_consent
adequate 108 116 1977 1985 I-contraception_consent
contraception 117 130 1986 1999 I-contraception_consent
( 131 132 2000 2001 O
e.g. 132 136 2001 2005 O
, 136 137 2005 2006 O
oral 138 142 2007 2011 B-contraception_consent
contraceptive 143 156 2012 2025 I-contraception_consent
, 156 157 2025 2026 O
double 158 164 2027 2033 B-contraception_consent
barrier 165 172 2034 2041 I-contraception_consent
method 173 179 2042 2048 I-contraception_consent
, 179 180 2048 2049 O
intra 181 186 2050 2055 B-contraception_consent
- 186 187 2055 2056 I-contraception_consent
uterine 187 194 2056 2063 I-contraception_consent
device 195 201 2064 2070 I-contraception_consent
, 201 202 2070 2071 O
intra 203 208 2072 2077 B-contraception_consent
- 208 209 2077 2078 I-contraception_consent
muscular 209 217 2078 2086 I-contraception_consent
contraceptive 218 231 2087 2100 I-contraception_consent
) 231 232 2100 2101 O

Platelet 0 8 2102 2110 B-clinical_variable
count 9 14 2111 2116 I-clinical_variable
≥100 15 19 2117 2121 O
x 20 21 2122 2123 I-lower_bound
109 22 25 2124 2127 I-lower_bound
/ 25 26 2127 2128 I-lower_bound
L 26 27 2128 2129 I-lower_bound

Pregnant 0 8 2130 2138 B-pregnancy

Prior 0 5 2139 2144 B-treatment
chemotherapy 6 18 2145 2157 I-treatment
, 18 19 2157 2158 O
other 20 25 2159 2164 O
investigational 26 41 2165 2180 B-treatment
agents 42 48 2181 2187 I-treatment
, 48 49 2187 2188 O
or 50 52 2189 2191 O
radiation 53 62 2192 2201 B-treatment
must 63 67 2202 2206 O
be 68 70 2207 2209 O
discontinued 71 83 2210 2222 O
for 84 87 2223 2226 O
at 88 90 2227 2229 O
least 91 96 2230 2235 O
28 97 99 2236 2238 B-lower_bound
days 100 104 2239 2243 I-lower_bound
prior 105 110 2244 2249 I-lower_bound
to 111 113 2250 2252 O
the 114 117 2253 2256 O
first 118 123 2257 2262 O
administration 124 138 2263 2277 O
of 139 141 2278 2280 O
COTI-2 142 148 2281 2287 B-treatment

Prothrombin 0 11 2288 2299 B-clinical_variable
time 12 16 2300 2304 I-clinical_variable
( 17 18 2305 2306 I-clinical_variable
PT 18 20 2306 2308 I-clinical_variable
) 20 21 2308 2309 I-clinical_variable
or 22 24 2310 2312 O
international 25 38 2313 2326 B-clinical_variable
normalize 39 48 2327 2336 I-clinical_variable
rate 49 53 2337 2341 I-clinical_variable
( 54 55 2342 2343 I-clinical_variable
INR 55 58 2343 2346 I-clinical_variable
) 58 59 2346 2347 I-clinical_variable
within 60 66 2348 2354 O
1.5x 67 71 2355 2359 B-upper_bound
upper 72 77 2360 2365 I-upper_bound
limit 78 83 2366 2371 I-upper_bound
of 84 86 2372 2374 I-upper_bound
normal 87 93 2375 2381 I-upper_bound

Supraventricular 0 16 2382 2398 B-chronic_disease
arrhythmias 17 28 2399 2410 I-chronic_disease
including 29 38 2411 2420 O
atrial 39 45 2421 2427 B-chronic_disease
fibrillation 46 58 2428 2440 I-chronic_disease
, 58 59 2440 2441 O
which 60 65 2442 2447 O
are 66 69 2448 2451 O
uncontrolled 70 82 2452 2464 O

The 0 3 2465 2468 O
presence 4 12 2469 2477 O
of 13 15 2478 2480 O
or 16 18 2481 2483 O
imminent 19 27 2484 2492 O
occurrence 28 38 2493 2503 O
of 39 41 2504 2506 O
airway 42 48 2507 2513 B-chronic_disease
obstruction 49 60 2514 2525 I-chronic_disease
, 60 61 2525 2526 O
unless 62 68 2527 2533 O
tracheostomy 69 81 2534 2546 B-treatment
in 82 84 2547 2549 O
place 85 90 2550 2555 O

Total 0 5 2556 2561 B-clinical_variable
bilirubin 6 15 2562 2571 I-clinical_variable
within 16 22 2572 2578 O
normal 23 29 2579 2585 O
limits 30 36 2586 2592 O

Toxicity 0 8 2593 2601 B-clinical_variable
from 9 13 2602 2606 O
prior 14 19 2607 2612 B-treatment
therapy 20 27 2613 2620 I-treatment
( 28 29 2621 2622 O
except 29 35 2622 2628 O
alopecia 36 44 2629 2637 B-chronic_disease
) 44 45 2637 2638 O
has 46 49 2639 2642 O
resolved 50 58 2643 2651 O
to 59 61 2652 2654 O
≤Grade 62 68 2655 2661 O
1 69 70 2662 2663 I-upper_bound

Urine 0 5 2664 2669 B-clinical_variable
protein 6 13 2670 2677 I-clinical_variable
< 14 15 2678 2679 O
500 15 18 2679 2682 B-upper_bound
mg 19 21 2683 2685 I-upper_bound
or 22 24 2686 2688 O
urine 25 30 2689 2694 B-clinical_variable
protein 31 38 2695 2702 I-clinical_variable

Ventricular 0 11 2703 2714 B-chronic_disease
arrhythmias 12 23 2715 2726 I-chronic_disease
requiring 24 33 2727 2736 O
continuous 34 44 2737 2747 O
therapy 45 52 2748 2755 B-treatment

creatinine 0 10 2756 2766 B-clinical_variable
ratio 11 16 2767 2772 I-clinical_variable
( 17 18 2773 2774 I-clinical_variable
UPC 18 21 2774 2777 I-clinical_variable
) 21 22 2777 2778 I-clinical_variable
< 23 24 2779 2780 O
1.0 24 27 2780 2783 B-upper_bound

≥18 0 3 2784 2787 O
years 4 9 2788 2793 I-lower_bound
of 10 12 2794 2796 O
age 13 16 2797 2800 B-age

